The efficacy of Zonisamide for BPSD in Dementia with Lewy bodies. A randomized, single-blind, placebo-control trial.

Trial Profile

The efficacy of Zonisamide for BPSD in Dementia with Lewy bodies. A randomized, single-blind, placebo-control trial.

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Jun 2017

At a glance

  • Drugs Zonisamide (Primary)
  • Indications Lewy body disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Jun 2017 Results of post hoc analysis assessing effects of zonisamide on cognition and BPSD, presented at the 21st International Congress of Parkinson's Disease and Movement Disorders
    • 05 Aug 2016 Status changed from recruiting to completed.
    • 18 Jun 2015 Results presented at the 19th International Congress of Parkinson's Disease and Movement Disorders.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top